Stroke or coronary artery disease prediction from mean platelet volume in patients with type 2 diabetes mellitus

Platelets

Volumn 24, Issue 5, 2013, Pages 401-406

  Han, Jung Yeon ^a   Choi, Dong Hyun ^a   Choi, Seo Won ^a   Kim, Bo Bae ^a   Ki, Young Jae ^a   Chung, Joong Wha ^a   Koh, Young Youp ^a   Chang, Kyong Sig ^a   Hong, Soon Pyo ^a  

^a Chosun University   (South Korea)

Author keywords

Coronary artery disease; Diabetes mellitus; Korean; Mean platelet volume; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CREATININE; HEMOGLOBIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ALBUMINURIA; ANTICOAGULANT THERAPY; ARTICLE; BLOOD SAMPLING; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; CORONARY RISK; DYSLIPIDEMIA; EVENT FREE SURVIVAL; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; SURVIVAL RATE; THROMBOCYTE VOLUME; TRANSIENT ISCHEMIC ATTACK;

AGED; AREA UNDER CURVE; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEAN PLATELET VOLUME; MIDDLE AGED; PROGNOSIS; RISK; SENSITIVITY AND SPECIFICITY; STROKE;

MOROCCAN PEPPER VIRUS;

EID: 84879759415     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2012.710858     Document Type: Article

References (25)

1. Plutzky J. Macrovascular effects and safety issues of therapies for type 2 diabetes. Am J Cardiol 2011;108:25B-32B
2. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Sue Kirkman M. Aspirin for primary prevention of cardiovascular events in people with diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation. Circulation 2010;121(24):2694-2701
3. Butalia S, Leung AA, Ghali WA, Rabi DM. Aspirin effect on the incidence of major adverse cardiovascular events in patients with diabetes mellitus: A systematic review and meta-analysis. Cardiovasc Diabetol 2011;10:25
4. Nandish S, Wyatt J, Bailon O, Smith M, Oliveros R, Chilton R. Implementing cardiovascular risk reduction in patients with cardiovascular disease and diabetes mellitus. Am J Cardiol 2011;108:42B-51B
5. Arjomand H, Roukoz B, Surabhi SK, Cohen M. Platelets and antiplatelet therapy in patients with diabetes mellitus. J Invasive Cardiol 2003;15(5):264-269
6. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: A link between thrombosis and inflammatioñCurr Pharm Des 2011;17(1):47-58
7. Bath PM, Butterworth RJ. Platelet size: Measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7(2):157-161
8. Gasparyan AY, Stavropoulos-Kalinoglou A, Toms TE, Douglas KM, Kitas GD. Association of mean platelet volume with hypertension in rheumatoid arthritis. Inflamm Allergy Drug Targets 2010;9(1):45-50
9. Yazici S, Yazici M, Erer B, Calik Y, Ozhan H, Ataoglu S. The platelet indices in patients with rheumatoid arthritis: Mean platelet volume reflects disease activity. Platelets 2010;21(2):122-125
10. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, Lakasas G. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004;15(8):475-478
11. Pathansali R, Smith N, Bath P. Altered megakaryocyte-platelet haemostatic axis in hypercholesterolaemia. Platelets 2001;12(5):292-297
12. Park BJ, Shim JY, Lee HR, Jung DH, Lee JH, Lee YJ. The relationship of platelet count, mean platelet volume with metabolic syndrome according to the criteria of the American Association of Clinical Endocrinologists: A focus on gender differences. Platelets 2012;23(1):45-50
13. Unubol M, Ayhan M, Guney E. The relationship between mean platelet volume with microalbuminuria and glycemic control in patients with type II diabetes mellitus. Platelets 2011. Epub 2011/ 11/30
14. Bath P, Algert C, Chapman N, Neal B. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35(3):622-626
15. Ha SI, Choi DH, Ki YJ, Yang JS, Park G, Chung JW, Koh YY, Chang KS, Hong SP. Stroke prediction using mean platelet volume in patients with atrial fibrillation. Platelets 2011;22(6):408-414
16. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33:S11-S61
17. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97(18):1837-1847
18. Brummitt DR, Barker HF. The determination of a reference range for new platelet parameters produced by the Bayer ADVIA120 full blood count analyser. Clin Lab Haematol 2000;22(2):103-107
19. Song YH, Park SH, Kim JE, Ahn JY, Seo YH, Park PH, Kim KH. Evaluation of platelet indices for differential diagnosis of thrombocytosis by ADVIA 120. Korean J Lab Med 2009;29(6):505-509
20. Ntaios G, Gurer O, Faouzi M, Aubert C, Michel P. Hypertension is an independent predictor of mean platelet volume in patients with acute ischaemic stroke. Intern Med J 2011;41(9):691-695
21. Colkesen Y, Coskun I, Muderrisoglu H. The effect of aspirin on mean platelet volume in patients with paroxysmal atrial fibrillation. Platelets 2012. Epub 2012/06/01
22. Endler G, Klimesch A, Sunder-Plassmann H, Schillinger M, Exner M, Mannhalter C, Jordanova N, Christ G, Thalhammer R, Huber K, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol 2002;117(2):399-404
23. Kilicli-Camur N, Demirtunc R, Konuralp C, Eskiser A, Basaran Y. Could mean platelet volume be a predictive marker for acute myocardial infarctioñMed Sci Monit 2005;11(8):CR387-CR392
24. Gasparyan AY, Watson T, Lip GY. The role of aspirin in cardiovascular prevention: Implications of aspirin resistance. J Am Coll Cardiol 2008;51(19):1829-1843
25. Gasparyan AY. Aspirin and clopidogrel resistance: Methodological challenges and opportunities. Vasc Health Risk Manag 2010;6:109-112